Global Antiviral Medications for Seasonal Influenza Market Growth 2025-2031

Report ID: 3111094 | Published Date: Apr 2026 | No. of Page: 80 | Base Year: 2025 | Rating: 4.7
Request Sample Report
Pre-Order Enquiry

The global Antiviral Medications for Seasonal Influenza market size is predicted to grow from US$ 980 million in 2025 to US$ 1500 million in 2031; it is expected to grow at a CAGR of 7.4% from 2025 to 2031.

Seasonal influenza antiviral drugs are a class of drugs specifically used to prevent and treat seasonal influenza caused by influenza viruses. These drugs work by directly acting on the virus or inhibiting its replication process, thereby alleviating symptoms, shortening the course of the disease, and reducing the risk of complications. Common antiviral drugs include neuraminidase inhibitors and M2 ion channel inhibitors.

Key Features

  • Global market growth from US$ 980 million to US$ 1500 million.
  • CAGR of 7.4% from 2025 to 2031.

Segmentation by Type

  • Baloxavir marboxil
  • Oseltamivir
  • Zanamivir
  • Peramivir

Segmentation by Application

  • Influenza A
  • Influenza B

Market by Region

  • Americas
  • APAC
  • Europe
  • Middle East & Africa

Company Coverage

  • Roche
  • HEC Pharma
  • Qilu Pharmaceutical
  • CSPC
  • Kelun

Key Questions Addressed in this Report

  1. What is the 10-year outlook for the global Antiviral Medications for Seasonal Influenza market?
  2. What factors are driving Antiviral Medications for Seasonal Influenza market growth, globally and by region?
  3. Which technologies are poised for the fastest growth by market and region?
  4. How do Antiviral Medications for Seasonal Influenza market opportunities vary by end market size?
  5. How does Antiviral Medications for Seasonal Influenza break out by Type, by Application?
Frequently Asked Questions
Antiviral Medications for Seasonal Influenza report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Antiviral Medications for Seasonal Influenza report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Antiviral Medications for Seasonal Influenza report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports